INTRODUCTION
Treatment studies have identified self-efficacy (as measured by the Drinking Refusal Self-Efficacy Questionnaire, DRSEQ [27, 41] ) as the only significant mediator of treatment outcomes when readiness to change, perceived risk, norm estimates and positive drinking expectancies were also considered [42] . However, Kadden and Litt's [19] review on substance abuse self-efficacy concludes that the increased recent interest in the role of selfefficacy as a mediator of substance abuse problems would benefit from further empirical support. A mediating role for self-efficacy makes theoretical and clinical sense. Almost two decades ago, Oei and Baldwin [43] noted that when an individual is presented with a decision, the outcome will also be dependent upon the strength of the individual's belief that they are able to resist or refuse alcohol.
SCT has had considerable impact on our understanding of human behaviour, and along with other cognitive models, has profoundly influenced our understanding of the use and maintenance of substance use disorders [44, 45] . Evidence suggests that consideration of concurrent expectancy and self-efficacy beliefs provides more powerful prediction of use and treatment outcome. More recent research points to a meditational process. Psychometrically robust cannabis expectancy and cannabis self-efficacy measures are now available [18, 26] .
Of interest in this study is the unexplored relationship between expectancies and self efficacy in a cannabis sample in treatment. Based on previous research, we expect that both constructs will be significantly associated with cannabis use and dependence. We further anticipate that self-efficacy will mediate expectancy across these severity indices.
METHOD Participants
Data were obtained from 1115 individuals referred for cannabis assessment as part of an illicit drug diversion initiative. The diversion program consists of a 2-hour comprehensive assessment of substance use and psychosocial functioning incorporating motivational interviewing. Referral to further treatment is provided, if indicated. Data collection from the program is ongoing and previous psychometric measurement studies have analysed subsamples of this dataset [18, 26] 
Measures
Cannabis Expectancy Questionnaire (CEQ) [17, 18] . The CEQ is a 45-item questionnaire assessing positive (18 items, e.g., "I get better ideas when smoking cannabis") and negative (27 items, e.g., "I am more worried about what others are saying about me when I am smoking cannabis") cannabis use outcome expectancies. Items included a five-point, Likert-style response format (1 = Strongly Disagree to 5 = Strongly Agree). The questionnaire was initially developed with a community sample and validated on a large sample of cannabis users recruited from an outpatient clinic. The two subscales have 8 excellent internal reliability (α ≥ .90), and the CEQ's factor structure and criterion validity have been established across two samples [18] . [25, 26] . The CRSEQ is a 14-item questionnaire assessing an individual's belief in their ability to resist smoking cannabis across various situations. Items ask respondents to rate their ability to resist smoking cannabis on a 6-point Likert-type scale ranging from 1 (I am very sure I could NOT resist smoking cannabis) to 6 (I am very sure I could resist smoking cannabis). Similar to the Drinking Refusal Self-Efficacy Questionnaire [27], it comprises three subscales: Emotional Relief SelfEfficacy (6 items; e.g., "When I feel upset"), Opportunistic Self-Efficacy (5 items; e.g., "When someone offers me a smoke"), and Social Facilitation Self-Efficacy (3 items; e.g., "When I want to feel more confident"). Like the CEQ, the questionnaire was developed with a community sample and validated on a large sample of cannabis users recruited from an outpatient treatment service. The questionnaire's internal reliability is good-to-excellent (α = .84 to .97), and its factor structure and criterion validity has been previously established [26] . [46, 47] . The SDS is a 5-item questionnaire that is sensitive to severity of cannabis dependence [46] . Using Australian normative data, the SDS-C cut-off for likely cannabis dependence is ≥ 3 [47] .
Cannabis Refusal Self-Efficacy Questionnaire (CRSEQ)

Severity of Dependence Scale-Cannabis (SDS-C)
Cannabis Use was assessed by Masters-and PhD-qualified clinical psychologists using a retrospective diary approach over the past week. Psychologists had between 2 and 25 years alcohol and drug treatment experience (M = 10.5 years). If cannabis was not consumed in the past week, an estimate of typical weekly consumption was recorded. For the purposes of this study, 'joints' (cannabis cigarette) were quantified as 0.25 grams of cannabis, and 'cones' (use of 'bong' or 'pipe'), 0.10 grams of cannabis.
Data analysis
Structural equation modelling (SEM) was conducted in R (version 2.15.2) using the lavaan package (version 0.5-10) [48] . The hypothesized mediation model was tested using maximum likelihood estimation. The three subcomponents of cannabis refusal self-efficacy were operationalized as latent factors, with their items serving as indicators, all loading onto a higher-order refusal self-efficacy latent factor [26] . Due to the number of items on the CEQ, positive and negative cannabis expectancy were operationalised as latent factors with parcels of items serving as indicators. Item parcels were created by assigning individual CEQ items to parcels on an alternating basis (e.g., item 1 to parcel 1, item 2 to parcel 2, item 3 to parcel 3, and so on) [as per 39, 49] .
The χ 2 test was utilized as a statistical test of model fit (α = .050) [50, 51] . The comparative fit index (CFI), root mean-square error of approximation (RMSEA), and standardized root mean-square residual (SRMR) were also used to evaluate fit [50] . The following rules-of-thumb were employed to evaluate model fit. For "good" fit: CFI ≥ .95, RMSEA ≤ .06, SRMR ≤ .08 [51] . Mediation was tested in two ways. First, the hypothesized full mediation model was compared to alternative partial mediation models using the chisquare difference test (Δχ 2 ) [52] . Second, the mediation effect itself was estimated with the RMediation package [53] using the distribution-of-the-product method, which is the optimal approach to test mediation [54] .
RESULTS
There were data missing on CRSEQ items (range = 14.3% to 25.8%) and all CEQ item parcels (range = 13.1% to 25.7% Missing data were imputed using Full Information Maximum Likelihood (FIML) estimation, an optimal strategy for handling missing data [55] . Age and sex were included in the model as auxiliary variables and data were consequently assumed to be Missing at Random (MAR) [55] .
The hypothesized full mediation model provided a good fit to the data ( Model 2 ). An additional model was also tested that specified extra paths from positive and negative expectancy to dependence severity. This model provided the best fit to the data and accounted for 7% and 20% of the variance in weekly consumption and dependence severity, respectively (Table 1 Cannabis refusal self-efficacy fully mediated the association between positive expectancy and severity of dependence (unstandardized mediation effect, CI95% = 0.04, 0.10). However, refusal self-efficacy only partially mediated the effect of negative expectancy on dependence severity (unstandardized mediation effect, CI95% = 0.02, 0.06).
Negative expectancy still had a significant direct association with severity of dependence (unstandardized coefficient = 0.21, SE = 0.03, p < .001).
______________________
Insert Table 1 Cognitive Theory (SCT) [6, 7] , this is the first study to examine the possible mediational relationship between expectancy and self-efficacy beliefs, as observed in other substance use.
We applied newly developed, robust psychometric tools to a large clinical sample of cannabis users in treatment (N = 1115). Findings provide partial support for a meditational relationship between cannabis expectancies and cannabis refusal self-efficacy (see Table 2 ; Figure 1 ).
Cannabis refusal self-efficacy fully mediated negative expectancy in predicting consumption and fully mediated positive expectancy in predicting dependence severity.
Insert Table 2 about here
We confirm previous reports [14, 18] that positive cannabis expectancies, but not negative expectancies, were a direct and significant predictor of cannabis consumption. Full mediation was observed when self-efficacy beliefs and negative expectations were combined in the one model, identifying a previously unreported pathway to cannabis consumption.
Consistent with the SCT hypothesis, cannabis refusal self-efficacy played a mediating role predicting cannabis dependence severity. Full mediation was observed for positive expectancy, partial mediation for negative expectancy. Positive expectancies were only associated with cannabis severity via their association with low self-efficacy beliefs. Negative expectancies were directly associated with dependence severity, as well as indirectly though self-efficacy factors.
The study has limitations. While the sample size for treatment seeking cannabis users is large and measurement robust, the cross-sectional design does not allow an assessment of causality. In analogous research, prospective alcohol studies suggest that alcohol expectancies develop early, even vicariously [56] , and play a significant role in predicting future alcohol problems [40] . Low self-efficacy beliefs are associated with post-treatment abstinence [57, 58] . We cannot determine from these data if similar trajectories are evident for cannabis, as for alcohol. The findings may not be generalizable to all treatment seeking 13 samples and in particular we also had a high proportion of males. Biological markers of cannabis use over a longer period would have strengthened confidence in self-report consumption data. Greater power from expectancies and self-efficacy in predicting cannabis use over specific periods may be obtained if the assessment focuses more closely on that period, which may not be the same as those before or afterwards. SCT emphasises the contextual grounding of both self-efficacy (the specific task difficulty, physiological and emotional state, and amount of effort that the person expects to expend) and outcome expectancies. The expected outcomes of further cannabis use prior to finalisation of the clinical and forensic issues in the current sample may be different from the expected outcomes in the past or future.
The current findings indicate that modification of high negative and positive expectancies may be equally important targets in psychological interventions aimed at reducing consumption. Consistent with Bandura [8, 9] , low self-efficacy beliefs could be the final contributing pathway to heavier cannabis consumption. These are likely to provide additional efficacy as targets in cannabis prevention and treatment. In alcohol dependence, treatments aimed at developing alcohol refusal skills are effective, with therapeutic effects being mediated by increased self-efficacy [59] . By contrast, direct alcohol expectancy challenges have shown only modest efficacy, at least in prevention studies [60] . Given the strong association between expectancies and refusal self-efficacy found for both alcohol and cannabis, future research needs to investigate if added benefit occurs by combining these two approaches. Results reported here suggest that this could provide incremental benefit.
Consistent with previous theoretical and empirical alcohol studies, both cannabis expectancy and cannabis refusal self-efficacy were significant predictors of cannabis problems. When mediation was formally examined, partial support was observed for self-
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